Britecyte

Lipoderma is an aesthetic brand by Britecyte, a company founded in 2020 to develop human cell and tissue-based therapies. Its flagship product is a human adipose allograft designed to restore natural fat lost through aging, weight loss, or other life changes. Rather than using synthetic filler to add volume, Lipoderma aims to replace lost adipose tissue with donated human fat, supporting the soft structure beneath the skin and helping people look more like themselves.

The product is offered for facial and hand restoration, including areas such as the midface, under-eyes, and hands. It comes in 1.5 cc vials for precision placement and 10 cc vials for larger-volume restoration, and is available through a selective network of experienced providers. Britecyte describes Lipoderma as an elective, self-pay treatment, with provider-guided plans and results that develop as the tissue integrates over time. The company also offers provider search tools, patient outcome information, and educational resources about the science, procedure, recovery, and suitability of natural fat restoration, including after GLP-1-assisted weight loss.